BlueCrest Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

BlueCrest Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,989	Closed	-$267K	–	1200
2016 Q1	$267K	Buy	+4,989	New	+$368K	0.02%	612

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

BlueCrest Capital Management's ANAC Position: Q2 2016 in Review

BlueCrest Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,989 shares — an estimated $267K sold.

BlueCrest Capital Management first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $267K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

BlueCrest Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
BlueCrest Capital Management sold 4,989 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $267K.
BlueCrest Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
BlueCrest Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $267K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on BlueCrest Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.